|
Session 115
Poster Abstracts
Transmitted Drug Resistance: Epidemiology and Pathogenesis
Monday, 1 - 4 pm
Poster Hall |
648
 |
Antiretroviral Drug-resistance Mutations and Subtypes in Drug-naïve Persons Newly Diagnosed with HIV-1 Infection, US, March 2003 to October 2006
W Wheeler1, K Mahle1, Ulana Bodnar*2, R Kline2, I Hall2, M McKenna2, and the US Variant, Atypical and Resistant HIV Surveillance (VARHS) Group
1Northrop Grumman Corp, Atlanta, GA, US and 2CDC, Atlanta, GA, US |
649
|
HIV Drug Resistance Transmission Threshold Survey in High- and Low-risk Populations in Bangkok
Sunee Sirivichayakul*1, P Phanuphak2, T Pankam2, R O-Charoen3, D Sutherland4, and K Ruxrungtham1
1Chulalongkorn Univ, Bangkok, Thailand; 2Thai Red Cross AIDS Res Ctr, Bangkok; 3Thai Red Cross Natl Blood Ctr, Bangkok; and 4WHO, Geneva, Switzerland |
| 650 |
ART Resistance, HIV-1 Tropism, and HIV-1 Subtype among Men Who Have Sex with Men Recently Infected with HIV-1 in the US: The EXPLORE Study
Susan H. Eshleman*1, M Husnik2, S Hudelson1, D Donnell2, Y Huang3, W Huang4, J Jackson1, T Coates5, M Chesney6, and B Koblin7
1Johns Hopkins Univ Sch of Med, Baltimore, MD, US; 2Fred Hutchinson Cancer Res Ctr, Seattle, WA, US; 3Emory Univ, Atlanta, GA, US; 4Monogram Biosci, South San Francisco, CA, US; 5Univ of California, Los Angeles, US; 6NIH, Bethesda, MD, US; and 7New York Blood Ctr, New York, NY, US |
| 651 |
Recent Trends in Transmitted Drug Resistance in a New York City Cohort
Andrea Low*1,2, Andrea Low*1,2, H Mohri1, M Markowitz1,2, and M Markowitz1,2
1Aaron Diamond AIDS Res Ctr, The Rockefeller Univ, New York, NY, US and 2The Rockefeller Univ, New York, NY, US |
| 652 |
Surveillance for Transmitted Drug-resistance in Sentinel-sites: San Francisco, 2005-2006
Nicola Zetola*1, K Ahrens2, C Kent2, H H Truong3, R Grant3, J Dilley4, and J Klausner2
1Univ of California, San Francisco, US; 2San Francisco Dept of Publ Hlth, CA, US; 3Univ of California, San Francisco Gladstone Inst of Virology and Immunology, US; and 4AIDS Hlth Project, San Francisco, CA, US |
| 653 |
HIV Genotypic Resistance in Seroconverters in the gp120 Vaccine Efficacy Trial
Michael Para*1, J Fuchs2, C Celum3, R Novak4, M Gurwith5, K Mayer6, A Youngpairoj7, M Kalish7, W Heneine7, and M Ackers7
1Ohio State Univ, Columbus, US; 2San Francisco Dept of Publ Hlth, CA, US; 3Univ of Washington, Seattle, US; 4Univ of Illinois at Chicago, US; 5VaxGen, Inc, Brisbane, CA, US; 6Fenway Community Hlth Ctr, Boston, MA, US; and 7CDC, Atlanta, GA, US |
654
|
Age Discordance and Drug Resistance Predict Clustering of HIV among Recently Infected MSM in San Diego, California
Lydia Drumright*1, S Little1, D Richman1,2, D Richman1,2, and S Frost1
1Univ of California, San Diego, US and 2VA San Diego Hlthcare System, CA, US |
655
|
Surveillance of Transmitted HIV Drug Resistance among Women Attending Antenatal Clinics in Dar es Salaam, Tanzania
G Somi1, T Kibuka2, K Diallo3, T Tuhuma1, Sidibe Kassim*3, D Bennett4, C Yang3, C Kagoma5, E Lyamuya6, and R Swai1
1Natl AIDS Control Prgm, Dar es Salaam, Tanzania; 2CDC Tanzania, Dar es Salaam; 3CDC, Atlanta, GA, US; 4WHO, Geneva, Switzerland; 5WHO, Dar es Salaam, Tanzania; and 6Muhimbili Univ Coll of Hlth Sci, Dar es Salaam, Tanzania |
| 656 |
Transmission of HIV Strains with Resistance to PI and to Multiple Drug Classes Is Growing in Spain
Carmen de Mendoza*1, C Rodriguez2, F Gutierrez3, E Caballero4, J Colomina5, A Aguilera6, J Aguero7, C Tuset8, J Torre-Cisneros9, V Soriano1, and on behalf of the Spanish HIV Seroconverter Study Group.
1Hosp Carlos III, Madrid, Spain; 2Ctr Sanitario Sandoval, Madrid, Spain; 3Hosp Gen, Elche, Spain; 4Hosp Vall d'Hebron, Barcelona, Spain; 5Hosp de la Ribera, Valencia, Spain; 6Hosp Xeral, Santiago, Spain; 7Hosp Marques de Valdecilla, Santander, Spain; 8Hosp Gen, Valencia, Spain; and 9Hosp Reina Sofia, Cordoba, Spain |
657
|
Acquisition of Transmitted Drug-resistant HIV-1 Infection Is Associated with the Presence of Sexually Transmitted Infections
Kate Nambiar*1, M Fisher1, D Pao1, D Sudarshi1, I Reeves1, G Dean1, G Murphy2, J Parry2, and D Pillay3
1Brighton and Sussex Univ Hosp, Brighton, UK; 2Hlth Protection Agency, Colindale, London, UK; and 3Univ Coll and Royal Free Hosp Med Sch, London, UK |
|
